CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)	At The Market Offering Common Stock Common stock - voting	At The Market Offering Additional paid-in capital	At The Market Offering	Common Stock Common stock - voting Iliad	Common Stock Common stock - voting Irving	Common Stock Common stock - voting	Common Stock Common stock - non-voting	Additional paid-in capital Iliad	Additional paid-in capital Irving	Additional paid-in capital	Noncontrolling Interest	Accumulated deficit	Accumulated other comprehensive loss	Iliad	Irving	Total
Beginning Balance at Dec. 31, 2021										$ 231,105,000	$ 242,000	$ (219,494,000)				$ 11,853,000
Beginning Balance (in shares) at Dec. 31, 2021						644,700	2,120,786
Increase (decrease) in Stockholders' Equity (Deficit)
Issuance of common stock		$ 9,111,000	$ 9,111,000
Issuance of common stock (In shares)	267,286
Shares issued to third party for services										14,000						14,000
Shares issued to third party for services (in shares)						333
Shares issued in exchange of notes payable and accrued interest								$ 4,233,000						$ 4,233,000
Shares issued in exchange of notes payable and accrued interest (in shares)				115,333
Stock-based compensation										1,063,000						1,063,000
Net loss											(178,000)	(17,986,000)				(18,164,000)
Translation Loss																0
Ending Balance at Mar. 31, 2022										245,526,000	64,000	(237,480,000)				8,110,000
Ending Balance (in shares) at Mar. 31, 2022						1,027,652	2,120,786
Beginning Balance at Dec. 31, 2021										231,105,000	242,000	(219,494,000)				11,853,000
Beginning Balance (in shares) at Dec. 31, 2021						644,700	2,120,786
Ending Balance at Dec. 31, 2022										266,971,000	(699,000)	(266,948,000)	$ (680,000)			(1,356,000)
Ending Balance (in shares) at Dec. 31, 2022						2,182,084	2,120,786
Increase (decrease) in Stockholders' Equity (Deficit)
Issuance of common stock	$ 1,000	$ 17,864,000	$ 17,865,000
Issuance of common stock (In shares)	10,463,983
Shares issued in exchange of notes payable and accrued interest								$ 1,275,000	$ 627,000					$ 1,275,000	$ 627,000
Shares issued in exchange of notes payable and accrued interest (in shares)				1,370,005	150,000
Stock Issued During Period, Value, Third Party For Services										166,000						166,000
Shares issued to other third party for services (in shares)						9,669
Shares issued to other third party for services										166,000						166,000
Additional investments from non-controlling interests											1,232,000					1,232,000
Stock-based compensation										480,000						480,000
Net loss											(195,000)	(12,202,000)				(12,397,000)
Translation Loss											(28,000)		(204,000)			(232,000)
Ending Balance at Mar. 31, 2023						$ 1,000				$ 287,383,000	$ 310,000	$ (279,150,000)	$ (884,000)			$ 7,660,000
Ending Balance (in shares) at Mar. 31, 2023						14,175,741	2,120,786